psalexa
SearchBar Icon

Immunotherapy Drugs Market by Type (Checkpoint Inhibitors [Brand {Humira, Rituxan/MabThera, Herceptin, Remicade, Enbrel}], Vaccines [Type {Preventive, Therapeutic}, Brand {Prevnar/Prevenar 13, Gardasil, ProQuad, Rotarix}]), by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), by End User (Hospitals & Clinics, Individuals), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Saudi Arabia, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

Immunotherapy Drugs Market (2013-2023)
Published Report Code Available Format Pages
 October 2018  LS11095    207

Place an order

USD 4900
USD 5900
USD 7500